SEP
RTO icon

Signature Equity Partners’s Rentokil RTO Stock Holding History

Signature Equity Partners’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
6,194
+1
+0% +$32 0.08% 214
2026
Q1 		$195K Buy
6,193
+1,220
+25% +$38.4K 0.1% 181
2025
Q4 		$147K Buy
+4,973
New +$138K 0.08% 215

Other funds holding RTO

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Signature Equity Partners's RTO Position: Q2 2026 in Review

Signature Equity Partners increased its Rentokil (RTO) stake by 0.02% in Q2 2026, buying an estimated $32 and bringing the position to 6,194 shares worth $177K. The position accounts for 0.08% of the portfolio, ranked #214.

Signature Equity Partners first reported a position in RTO in Q4 2025 and has held it in 3 quarters since. The position peaked at $195K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Signature Equity Partners held 6,194 shares of Rentokil worth $177K as of Q2 2026.
  • Signature Equity Partners bought 1 Rentokil share in Q2 2026, an estimated $32.
  • Rentokil made up 0.08% of Signature Equity Partners's portfolio in Q2 2026, its #214 holding.
  • Signature Equity Partners first reported a position in Rentokil in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Rentokil position peaked at $195K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.